Cargando…
Systemic and targeted steroids for the treatment of IgA nephropathy
Immunoglobulin A nephropathy (IgAN) is a common glomerulonephritis partially correlated with mucosal immune system dysfunction. Progressive renal failure occurs in many patients, with about 30–50% of the patients with IgAN developing end-stage kidney disease (ESKD). Many treatments have been used fo...
Autores principales: | Locatelli, Francesco, Del Vecchio, Lucia, Ponticelli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695509/ http://dx.doi.org/10.1093/ckj/sfad224 |
Ejemplares similares
-
Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023) -
Immune abnormalities in IgA nephropathy
por: Gentile, Micaela, et al.
Publicado: (2023) -
Expanding options of supportive care in IgA nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2023) -
Understanding patient needs and predicting outcomes in IgA nephropathy using data analytics and artificial intelligence: a narrative review
por: Schena, Francesco Paolo, et al.
Publicado: (2023) -
Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis
por: Lee, Mingfeng, et al.
Publicado: (2023)